MIT researchers have built an AI language model that learns the internal coding patterns of a yeast species widely used to manufacture protein-based drugs, then rewrites gene sequences to push protein ...

The final day covered ethical aspects of animal studies, including humane handling, dosing, sample collection and adherence to biosafety ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS ...

–Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

We recently published 12 Stocks Jim Cramer Talked About. Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks that Jim Cramer talked about. Chip designer Advanced Micro Devices, Inc. (NASDAQ ...

We have our eyes peeled for the roads, Mylar confetti, and beads, but now the DA's office says that we need to be on the lookout for designer drugs, and you may not have heard of some of them.

Speeding up drug discovery in the age of AI may come down to a concept that's comfortingly old-fashioned: Consulting a chemistry recipe book. It makes perfect sense. Designing a new synthetic molecule ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with a novel KRAS G12D inhibitor, a small preliminary study showed. The ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Dec 12 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...